Muttagi S S, Patil B R, Godhi A S, Arora D K, Hallikerimath S R, Kale A D
Department of Oral and Maxillofacial Surgery, KLE VK Institute of Dental Sciences, KLE University, Belgaum; Department of Surgical Oncology (Head and Neck), Karnataka Cancer Therapy and Research Institute, Hubli, Karnataka, India.
Department of Surgical Oncology, Karnataka Cancer Therapy and Research Institute, Hubli, Karnataka, India.
Indian J Cancer. 2016 Apr-Jun;53(2):239-243. doi: 10.4103/0019-509X.197724.
Lymph node yield (LNY) is a valid marker of prognosis in oral cancer. Precise estimation of LNY in Indian patients with T3/T4 gingivobuccal sulcus squamous cell carcinoma (GBS-SCC) has not been well documented. Hence, the primary objective of the study was to determine the LNY in patients with T3/T4 SCC of mandibular GBS, and the secondary objective was to study the association of LNY with clinicopathological factors such as tumor thickness, histological differentiation, number of positive nodes, and extracapsular spread (ECS).
Study patients comprised biopsy proven T3/T4 SCC of mandibular GBS that underwent unilateral surgery (composite or bite composite resection with level I to level V-neck dissection and pectoralis major flap reconstruction) at our center between January 2012 and October 2014. Grossing of surgical specimens was done as per the guidelines established by the Royal College of Pathologists (December 2009). The data were analyzed using SPSS software (22nd version) and Chi-square test.
The surgical specimens of 106 patients yielded 2329 lymph nodes with the mean LNY of 21.97 ± 5.57. Higher mean LNY of over 21 was significantly associated with ECS, number of positive nodes, delay in surgery over 15 days, skin involvement by the tumor, and presence of oral potentially malignant disorders.
With the single surgeon, pathologist and same surgical procedure, the mean LNY in Indian patients with T3/T4 SCC of mandibular GBS is 21.97 ± 5.57. Although clinicopathological factors affect the estimation of LNY, further studies are needed to validate the findings of this study.
淋巴结收获量(LNY)是口腔癌预后的有效指标。在印度T3/T4牙龈颊沟鳞状细胞癌(GBS-SCC)患者中,对LNY进行精确评估的相关记录并不完善。因此,本研究的主要目的是确定下颌GBS的T3/T4鳞状细胞癌患者的LNY,次要目的是研究LNY与肿瘤厚度、组织学分化、阳性淋巴结数量和包膜外扩散(ECS)等临床病理因素之间的关联。
研究对象为经活检证实为下颌GBS的T3/T4鳞状细胞癌患者,这些患者于2012年1月至2014年10月在我们中心接受了单侧手术(联合或咬肌联合切除术,同时进行I至V级颈清扫和胸大肌皮瓣重建)。手术标本的大体检查按照皇家病理学家学院制定的指南(2009年12月)进行。使用SPSS软件(第22版)和卡方检验对数据进行分析。
106例患者的手术标本共收获2329个淋巴结,平均LNY为21.97±5.57。平均LNY超过21与ECS、阳性淋巴结数量、手术延迟超过15天、肿瘤侵犯皮肤以及存在口腔潜在恶性疾病显著相关。
在由单一外科医生、病理学家且采用相同手术方式的情况下,印度下颌GBS的T3/T4鳞状细胞癌患者的平均LNY为21.97±5.57。尽管临床病理因素会影响LNY的评估,但仍需进一步研究来验证本研究的结果。